BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4996930)

  • 1. [The development of sulfonylurea late resistance].
    Angeli I
    Med Klin; 1970 Feb; 65(7):306-9. PubMed ID: 4996930
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glybenclamide and its place among sulfanylureas in the treatment of diabetes mellitus].
    Cabezas Cerrato J; Fernández-Cruz A; Fernández-Cruz A
    Rev Clin Esp; 1970 May; 117(4):375-86. PubMed ID: 5471527
    [No Abstract]   [Full Text] [Related]  

  • 3. Glibenclamide in the management of diabetes mellitus. I.
    Devlin JG; Manning K; Harty J
    J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).
    Lentini S; Bossini A; Pirola LC
    Arzneimittelforschung; 1972 Jul; 22(7):1169-73. PubMed ID: 4678124
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect and tolerance of HB 419 in out-patient treated diabetics].
    Bauer G; Kloppe W; Schubert PU
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1434-6. PubMed ID: 5394467
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary results with a new oral antidiabetic drug of the sulfanylurea series: glibenclamide or HB 419].
    Marocco F; Patrito G
    Minerva Med; 1970 Dec; 61(97):5525-42. PubMed ID: 5494124
    [No Abstract]   [Full Text] [Related]  

  • 7. [Our experience with Daonil. A new oral hypoglycemic agent].
    Rodriguez-Miñon JL; Arrieta F; Herrera JL
    Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progress in diabetes therapy using glibenclamide and phenformin. Report from the years 1967-1970 on 323 patients].
    Beyer J; Ewald W; Kunkel W; Wolf E; Schöffling K
    Dtsch Med Wochenschr; 1971 Apr; 96(17):728-33. PubMed ID: 5552854
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral sulphonylureas in the management of diabetes.
    Jackson WP
    S Afr Med J; 1971 Jan; 45(5):118-23. PubMed ID: 4925995
    [No Abstract]   [Full Text] [Related]  

  • 10. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.
    Emanueli A; Molari E; Pirola LC; Caputo G
    Arzneimittelforschung; 1972 Nov; 22(11):1881-5. PubMed ID: 4267009
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experience with the blood sugar reducing sulfonamide derivative glisoxepide].
    Petzoldt R; Riedesel G; Ramrath M; Grabs V; Haupt E; Schwedes U; Ewald W; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):429-32. PubMed ID: 4603399
    [No Abstract]   [Full Text] [Related]  

  • 12. Glipizide versus tolbutamide in maturity-onset diabetes, an open comparative study.
    Fuchs K
    Diabetologia; 1973 Sep; ():351-5. PubMed ID: 4772980
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral differential therapy of diabetes mellitus].
    Mehnert H
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1795-6. PubMed ID: 5451987
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical assessment of Gludiase in treatment of diabetes].
    Ponikowska I
    Pol Tyg Lek; 1971 May; 26(18):684-6. PubMed ID: 5090443
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of outpatient diabetics].
    Leubner H
    Wien Klin Wochenschr; 1970 Mar; 82(12):215-7. PubMed ID: 5439279
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
    Ninni M; Castelletta L
    Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucose tolerance in diabetes mellitus during treatment with the sulfonylurea hypoglycemic agents.
    Herman JB
    Isr J Med Sci; 1966; 2(6):733-7. PubMed ID: 5956689
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiences with oral antidiabetic HB 419 (glibenclamide)].
    Schöffling K; Petzoldt R; Althoff-Zucker C; Beyer J; Retiene K; Böhle E; Kunkel W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1439-45. PubMed ID: 5394468
    [No Abstract]   [Full Text] [Related]  

  • 19. [Late failures of oral therapy of diabetes].
    Kaeding A; Werner P
    Dtsch Z Verdau Stoffwechselkr; 1965 Nov; 25(5):305-12. PubMed ID: 5888991
    [No Abstract]   [Full Text] [Related]  

  • 20. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.